Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01817556Phase 4Completed
Phase 4, randomised, double-blind trial of Stillen in acute gastritis and chronic gastritis (2 arms), sponsored by Dong-A ST. Primary endpoint: Improvement rates of erosive gastritis at 4 weeks. Started Oct 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01817556.